Liquid drugs worth Rs 831 crore seized from Thane, Bharuch
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-08-09 07:00 GMT | Update On 2024-08-09 07:00 GMT
Advertisement
Ahmedabad: In a major crackdown, the Gujarat Anti-Terrorist Squad (ATS) raided a mephedrone manufacturing unit in Thane district of neighbouring Maharashtra, seizing liquid drug valued at Rs 800 crore, according to an official.
A similar operation was also carried out at a pharmaceutical factory in Bharuch district of Gujarat, where it recovered liquid Tramadol worth Rs 31 crore, he said.
During its operations conducted at both the places on August 5 and 6, the ATS nabbed four persons who were involved in the production and sale of these narcotic substances which are banned under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, said Sunil Joshi, Deputy Inspector General of Police, ATS.
Based on a specific tip-off, an ATS team raided an apartment in Bhiwandi town of Maharashtra on August 5 and nabbed Mohammad Yunus Shaikh (41) and his brother Mohammad Adil Shaikh (34) with nearly 800 kilograms of mephedrone (MD drug) in liquid form and worth Rs 800 crore in the international market, he told reporters.
Read also: Inter-state illegal pharma supply, manufacturing network busted by Punjab Police
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.